Company profile: Terumo Aortic
1.1 - Company Overview
Company description
- Provider of vascular and cardiovascular grafts and aortic repair solutions, designing and manufacturing sealed woven and knitted polyester grafts and devices for surgical, endovascular and hybrid aortic repair. Offerings include Thoraflex Hybrid, RelayPro for thoracic aortic disease, TREO for abdominal aortic aneurysms, and cardiothoracic and thoracoabdominal surgical designs.
Products and services
- RelayPro: A thoracic-specific endovascular stent graft system engineered to treat thoracic aortic disease, configured for endovascular aortic repair in the thoracic segment
- Thoraflex Hybrid: A hybrid device for aortic arch repair that integrates a stent graft with a surgical graft, enabling complex aortic surgeries across the arch
- TREO: An abdominal-specific endovascular stent graft system engineered to treat abdominal aortic aneurysms, supporting endovascular aortic repair within the abdominal vasculature
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Terumo Aortic
VasoMedical
HQ: United States
Website
- Description: Provider of non-invasive cardiovascular medical devices and patient monitoring systems, including EECP Therapy Systems for coronary artery disease and ischemic heart failure; the Lumenair All-In-One EECP system; MobiCare wireless multi-parameter patient monitoring; and VasoMedical-BIOX 2301/2303/2305 2-in-1 ECG Holter and ambulatory blood pressure monitoring recorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VasoMedical company profile →
LifeWatch
HQ: Switzerland
Website
- Description: Provider of remote cardiac monitoring and digital health solutions, offering wireless remote diagnostic patient monitoring services that deliver critical data for treatment decisions. Solutions include Philips Mobile Cardiac Telemetry (MCOT), Philips ePatch Extended Holter, Implantable Device Monitoring, EMR Integration, Telehealth Home Connect for at-home monitor application, and Remote INR patient self-testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LifeWatch company profile →
Cardurion Pharmaceuticals
HQ: United States
Website
- Description: Provider of cardiovascular therapeutics and research services, developing a PDE9 inhibitor for HFrEF and HFpEF to enhance existing therapy; a CaMKII inhibitor for CPVT, heart failure, and atrial fibrillation; and conducting clinical trials, plus medicinal chemistry, computational molecular modeling, and genetic engineering support for cardiovascular research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardurion Pharmaceuticals company profile →
Vidacare
HQ: United States
Website
- Description: Provider of intraosseous access devices for diagnostic, monitoring, and therapeutic applications. Develops, manufactures, and markets the EZ-IO Product System, designed to provide controlled vascular access through the intraosseous route.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vidacare company profile →
Carmat
HQ: France
Website
- Description: Provider of biocompatible, auto-regulated bioprosthetic total artificial hearts, including right and left ventricles designed to be as close as possible to the human heart; offers Aeson as an alternative therapeutic option for patients with advanced biventricular heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Carmat company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Terumo Aortic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Terumo Aortic
2.2 - Growth funds investing in similar companies to Terumo Aortic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Terumo Aortic
4.2 - Public trading comparable groups for Terumo Aortic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →